Travel reimbursement 2019 - US
| Reference number | |
| Coordinator | WarOnCancer AB |
| Funding from Vinnova | SEK 24 000 |
| Project duration | March 2019 - May 2019 |
| Status | Completed |
Important results from the project
The purpose of participating in SALSS in Washington DC was to meet strategic partners and potential investors for our expansion in the US market. We did both.
Expected long term effects
We met with strategic partners within the life-science industry and potential investors whom all showed a big interest in what we are building and the potential with WarOnCancer. This resultet in 4 booked meetings for a deeper discussion regarding investments and marketing possibilities for WarOnCancer in the US.
Approach and implementation
WarOnCancer participated in SALSS through a round-table discussion with leading life-science CEO:s, lead by Greg Simon - president of the Biden Cancer Initiative. WarOnCancer did also exhibit during the start-up exhibition event. This was a very good way to create interest and meet with the all the people attending.